CLASS III Drug recall · Reported 25 Mar 2020 · FDA Enforcement Report

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg) recalled

Strides Pharma Science is recalling Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), distributed nationwide in the US. The recall was initiated on 17 Feb 2020 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021
NDC64380-860, 64380-861
UPC0364380860068, 0364380861065
Quantity recalled2576 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1029-2020
FDA event ID
84968
Recalling firm
Strides Pharma Science, Bangalore
Manufacturer
Strides Pharma Science Limited
Classification
Class III
Status
Terminated
Recall initiated
17 Feb 2020
FDA classified
13 Mar 2020
Reported
25 Mar 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

17 Feb 2020Recall initiated by company
13 Mar 2020Classified by FDA+25 days
25 Mar 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Product as listed by the FDA

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Which lots are affected?

Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Potassium Chloride recalls

All 23
ReportedClassRecallCompanyReasonWhere
DrugCLASS IPotassium Chloride Inj., 20 mEq total in Flexible Container recalledPotassium ChlorideOtsuka ICU MedicalOtherNationwide
DrugCLASS IPotassium Chloride Inj., 10 mEq total in Flexible Container recalledPotassium ChlorideOtsuka ICU MedicalOtherNationwide
DrugCLASS IPotassium Chloride Inj., 20 mEq total in flexible container recalledPotassium ChlorideICU MedicalLabeling ErrorsNationwide
DrugCLASS IPotassium Chloride Inj., 10 mEq total recalled by ICU MedicalPotassium ChlorideICU MedicalOtherNationwide
DrugCLASS IIPotassium Chloride Extended-Release Tablets, USP, 10 mEq recalledPotassium ChlorideThe Harvard Drug GroupPotency & AssayNationwide